Flavio Mantelli

Trials

Studies that name Flavio Mantelli as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:52 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT07838506 · Phase 3, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Study Assessing the Safety and Efficacy of Urcosimod Ophthalmic Solution in Participants With Neuropathic Corneal Pain (NCP).

  Okyo Pharma Ltd · not yet recruiting · Neuropathic Corneal Pain · study director
• Ph2
  NCT06244316 · A Safety and Efficacy Study of 2 Dosing Regimens of Recombinant Human Nerve Growth Factor (rhNGF) Eye Drop Solution Compared With Vehicle in Patients With Dry Eye Disease.

  Dompé Farmaceutici S.p.A · completed · Dry Eye Disease · study director
• N/A
  NCT05552261 · DEFENDO Long Term Follow-up Study in Stage 1 NK Patients

  Dompé Farmaceutici S.p.A · completed · Neurotrophic Keratitis · study chair
• Ph3
  NCT05136170 · Study to Evaluate Safety and Efficacy of Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease

  Dompé Farmaceutici S.p.A · completed · Dry Eye Disease · study director
• Ph3
  NCT05133180 · Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study)

  Dompé Farmaceutici S.p.A · completed · Dry Eye · study director
• Ph4
  NCT04485546 · Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis

  Dompé Farmaceutici S.p.A · completed · Neurotrophic Keratitis · study chair
• Ph2
  NCT03982368 · A Study to Evaluate Safety and Efficacy of rhNGF Eye Solution vs Vehicle in Patients With Moderate to Severe Dry Eye

  Dompé Farmaceutici S.p.A · completed · Dry Eye Syndrome · study director
• Ph1
  NCT03836859 · Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

  Dompé Farmaceutici S.p.A · completed · Healthy Volunteers · study director
• N/A
  NCT03031327 · Safety and Efficacy of 2 Concentrations of Lubricin vs Sodium Hyaluronate in Ocular Discomfort After Refractive Surgery.

  Dompé Farmaceutici S.p.A · completed · Ocular Discomfort · study director
• N/A
  NCT02510235 · Tolerability, Safety and Efficacy of Lubricin vs Sodium Hyaluronate Eye Drops in Subjects With Moderate Dry Eye

  Dompé Farmaceutici S.p.A · completed · Dry Eye Syndrome, Tear Film Insufficiency · study director
• N/A
  NCT02507934 · Tolerability, Safety and Efficacy of Lubricin Versus Sodium Hyaluronate Eye Drops in Patients With Moderate Dry Eye

  Dompé Farmaceutici S.p.A · completed · Dry Eye Syndrome · study director
• Ph2
  NCT02227147 · Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK

  Dompé Farmaceutici S.p.A · completed · Neurotrophic Keratitis · study director
• Ph1/Ph2
  NCT02110225 · A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)

  Dompé Farmaceutici S.p.A · completed · Retinitis Pigmentosa · study director

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.